ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...
As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the globa ...
President Trump threatened to impose a 200% tariff on EU wines and champagne unless the EU rescinds its 50% tax on US alcohol ...
6d
Pharmaceutical Technology on MSNViking strikes $150m deal to secure supply of obesity drugViking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...
5d
Pharmaceutical Technology on MSNZealand and Roche strike $5.3bn obesity treatment dealThe two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.
Adjoa Andoh, Evangeline Lilly and Giorgio Moroder are set for tributes at the new Italian Global Series TV Festival that will ...
6don MSN
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results